08/02/2022 - 15:28

Chimeric adds scorpion toxin to cancer fight

08/02/2022 - 15:28


Upgrade your subscription to use this feature.

A protein derived from scorpion toxin being used to spearhead Chimeric Therapeutics’ assault on brain cancer cells has delivered encouraging early results from a study being conducted at the world-famous City of Hope Hospital in Los Angeles. Patients in the study responded well to the simultaneous introduction of the cell therapy by injecting it into both the tumours and the brain.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options